Benefits of adherence to anti-hypertensive drug therapy

European Heart Journal

Volumn 17, Issue SUPPL. A, 1996, Pages 16-20

  Flack, J M ^a   Novikov, S V ^a   Ferrario, C M ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Adherence; Hypertension; TOMHS

Indexed keywords

ACEBUTOLOL; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXAZOSIN; ENALAPRIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG HALF LIFE; FEMALE; HEADACHE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029872671     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/17.suppl_a.16     Document Type: Conference Paper

References (0)